Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PVT-401
Therapeutic Area : Gastroenterology
Study Phase : Preclinical
Sponsor : AbbVie Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Parvus Collaborates with AbbVie to Develop IBD Therapies Using Navacim Technology
Details : AbbVie partners with Parvus to develop immunotherapies for Inflammatory Bowel Disease (IBD) using Parvus' Navacim Treg platform, including PVT-401.
Product Name : PVT-401
Product Type : Peptide
Upfront Cash : Undisclosed
March 20, 2024
Lead Product(s) : PVT-401
Therapeutic Area : Gastroenterology
Highest Development Status : Preclinical
Sponsor : AbbVie Inc
Deal Size : Undisclosed
Deal Type : Collaboration